CTOS (@ctosociety) 's Twitter Profile
CTOS

@ctosociety

Medical professionals and scientists from around the world connect, collaborate, and share knowledge, experiences, and research for the treatment of sarcomas.

ID: 927881149153730560

linkhttp://www.ctos.org calendar_today07-11-2017 12:51:19

219 Tweet

1,1K Followers

284 Following

Pawel Sobczuk (@pawel_sobczuk) 's Twitter Profile Photo

Dario Callegaro presenting validation of CINSARC in pts with retroperitoneal sarcoma 🔸CINSARC is prognostic for OS and DFS 🔸CINSARC and Sarculator are correlated 🔸CINSARC do not improve prognostic value of Sarculator CTOS #CTOS2024 #CTOSTweeTOS

<a href="/DCalleMD/">Dario Callegaro</a> presenting validation of CINSARC in pts with retroperitoneal sarcoma
🔸CINSARC is prognostic for OS and DFS
🔸CINSARC and Sarculator are correlated
🔸CINSARC do not improve prognostic value of Sarculator
<a href="/ctosociety/">CTOS</a> #CTOS2024 #CTOSTweeTOS
CTOS (@ctosociety) 's Twitter Profile Photo

The second #CTOS2024 debate is coming soon! ☢️ hypofractionated radiotherapy - standard of care or not? Aisha Miah 🥊🥊Ashleigh Guadangnolo #CTOS2024 #CTOSTweeTOS

The second #CTOS2024 debate is coming soon!
☢️ hypofractionated radiotherapy - standard of care or not?
Aisha Miah 🥊🥊Ashleigh Guadangnolo
#CTOS2024 #CTOSTweeTOS
Pawel Sobczuk (@pawel_sobczuk) 's Twitter Profile Photo

Most awaited presentation of the year by Patrick Schöffski - BRIGTHLINE-1 trial - Brigimadlin 🆚 doxo in 1st line DDLPS ❌negative trial - no improvement in PFS 🔸mPFS 8,4 vs 7.1m HR 0.79 🔸 ORR 22 vs8.6% ⏭️what next? #CTOS2024 CTOS

Most awaited presentation of the year by <a href="/schoffski/">Patrick Schöffski</a> - BRIGTHLINE-1 trial - Brigimadlin 🆚 doxo in 1st line DDLPS
❌negative trial - no improvement in PFS 
🔸mPFS 8,4 vs 7.1m HR 0.79
🔸 ORR 22 vs8.6%
⏭️what next?
#CTOS2024 <a href="/ctosociety/">CTOS</a>
CTOS (@ctosociety) 's Twitter Profile Photo

We value your opinion about #CTOS2024, so don't forget to fill out the survey! Go to the meeting website💻or the app📲 and fill it out!

We value your opinion about #CTOS2024, so don't forget to fill out the survey!
Go to the meeting website💻or the app📲 and fill it out!
CTOS (@ctosociety) 's Twitter Profile Photo

#CTOS2024 came to an end! Thank you for participating and all the social media interactions! And please save the date for the #CTOS2025 in Boca Raton to 🥳celebrate together the 🎂30th Aniversary of CTOS! #CTOSTweeTOS

#CTOS2024 came to an end!
Thank you for participating and all the social media interactions! And please save the date for the #CTOS2025 in Boca Raton to 🥳celebrate together the 🎂30th Aniversary of CTOS!
#CTOSTweeTOS
CTOS (@ctosociety) 's Twitter Profile Photo

#CTOS2025 registration and abstract submission system is open! 🎉Don't miss the biggest #sarcoma meeting and unique celebration of CTOS's 30th anniversary! 🗓️ We are waiting for your abstracts until Jun 20th! More details on the meeting website ⏩ ctos.org/Meeting/2025An…

#CTOS2025 registration and abstract submission system is open!

🎉Don't miss the biggest #sarcoma meeting and unique celebration of CTOS's 30th anniversary!
🗓️ We are waiting for your abstracts until Jun 20th!

More details on the meeting website ⏩
ctos.org/Meeting/2025An…
CTOS (@ctosociety) 's Twitter Profile Photo

We are happy to announce the next #CTOS webinar! 📕Experts will discuss different approaches to Ewing #sarcoma in pediatric and adult populations 🗓️April 29th, 9am EST, 3pm CEST 💻more information and registration ctos.org/EducationalPro…

We are happy to announce the next #CTOS webinar!
📕Experts will discuss different approaches to Ewing #sarcoma in pediatric and adult populations
🗓️April 29th, 9am EST, 3pm CEST
💻more information and registration ctos.org/EducationalPro…
CTOS (@ctosociety) 's Twitter Profile Photo

CTOS President Silvia Stacchiotti is inviting everyone to join the Annual Meeting in Boca Raton and celebrate 30th Anniversary of the Society! Get ready and prepare your abstracts! Especially on the #sarcoma of the year 🌟#chondrosarcoma #CTOS2025 #CTOSTweeTOS

CTOS (@ctosociety) 's Twitter Profile Photo

After the inspiring ASCO meeting we are looking forward to meeting all the sarcoma family again at #CTOS2025! Patient advocacy groups are valuable members of our community! ⬇️Check the invitation from Kathrin Schuster from SPAGN and CTOS Outreach Committee

CTOS (@ctosociety) 's Twitter Profile Photo

🚨#CTOS2025 abstract submission alert! 🗓️The deadline for abstract submission has been extended until June 29th! Don't miss this unique opportunity to share your research data! This year, abstracts of oral presentations can also be published in ESMO Rare Cancers journal.

🚨#CTOS2025 abstract submission alert!

🗓️The deadline for abstract submission has been extended until June 29th!

Don't miss this unique opportunity to share your research data!
This year, abstracts of oral presentations can also be published in ESMO Rare Cancers journal.
CTOS (@ctosociety) 's Twitter Profile Photo

Only 5 days left to submit abstracts for #CTOS2025! Don't wait and send your abstracts today on our abstract portal ➡️ abstractscorecard.com/cfp/submit/log…

Only 5 days left to submit abstracts for #CTOS2025!

Don't wait and send your abstracts today on our abstract portal ➡️ abstractscorecard.com/cfp/submit/log…
CTOS (@ctosociety) 's Twitter Profile Photo

🚨Last hours to submit abstracts for #CTOS2025 You have time only until 11:59 PM EST to change the status of your submission into COMPLETE

🚨Last hours to submit abstracts for #CTOS2025

You have time only until 11:59 PM EST to change the status of your submission into COMPLETE